Juliann Chmielecki

Juliann Chmielecki

UNVERIFIED PROFILE

Are you Juliann Chmielecki?   Register this Author

Register author
Juliann Chmielecki

Juliann Chmielecki

Publications by authors named "Juliann Chmielecki"

Are you Juliann Chmielecki?   Register this Author

59Publications

3525Reads

15Profile Views

A Novel Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancy.

J Natl Compr Canc Netw 2018 03;16(3):238-242

From the Division of Gynecologic Oncology, Department of Reproductive Medicine, and Division of Hematology-Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California; Foundation Medicine, Inc., Cambridge, Massachusetts; and Division of Surgical Oncology, Department of Surgery, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.7039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053908PMC
March 2018

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability.

Cancer Res 2017 11 22;77(22):6313-6320. Epub 2017 Sep 22.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-1569DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690871PMC
November 2017

Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.

JAMA Oncol 2017 May;3(5):666-671

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania2Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania3Magee-Women's Research Institute, Magee-Women's Research Hospital of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania7Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.5630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508875PMC
May 2017

Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma.

J Natl Compr Canc Netw 2016 11;14(11):1345-1350

From Baylor Health Care System, Dallas, Texas; Foundation Medicine, Inc., Cambridge, Massachusetts; Penn Memory Center, Department of Neurology, Philadelphia, Pennsylvania; Albany Medical College, Albany, New York; and UT Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0145DOI Listing
November 2016

Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.

Oncologist 2016 Jan 15;21(1):33-9. Epub 2015 Dec 15.

Foundation Medicine, Inc., Cambridge, Massachusetts, USA; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://www.foundationmedicine.com/wp-content/uploads/2015/12
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2015-0241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709208PMC
January 2016

Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.

Oncologist 2015 Oct 2;20(10):1132-9. Epub 2015 Sep 2.

Foundation Medicine, Inc., Cambridge, Massachusetts, USA; Division of Hematology-Oncology, University of California Irvine, Orange, California, USA; The Ohio State University-James Cancer Hospital, Columbus, Ohio, USA; National Translational Research Group, New York, New York, USA; Albany Medical College, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591943PMC
October 2015

Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI.

Lung Cancer 2015 Sep 29;89(3):357-9. Epub 2015 Jun 29.

Division of Hematology-Oncology, Department of Medicine, Chao Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA 92868, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.06.021DOI Listing
September 2015

Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.

Oncologist 2015 May 16;20(5):499-507. Epub 2015 Apr 16.

Foundation Medicine Inc., Cambridge, Massachusetts, USA; Chao Family Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange, California, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; University of Chicago, Chicago, Illinois, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, USA; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425384PMC
May 2015

Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.

Cancer Res 2015 Jan 8;75(2):264-9. Epub 2014 Dec 8.

Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-1008DOI Listing
January 2015

Anchored multiplex PCR for targeted next-generation sequencing.

Nat Med 2014 Dec 10;20(12):1479-84. Epub 2014 Nov 10.

1] Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3729DOI Listing
December 2014

A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.

PLoS One 2014 31;9(1):e87361. Epub 2014 Jan 31.

Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America ; Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087361PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909098PMC
October 2014

DNA sequencing of cancer: what have we learned?

Annu Rev Med 2014 20;65:63-79. Epub 2013 Nov 20.

Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, Massachusetts 02115; email:

View Article

Download full-text PDF

Source
http://www.annualreviews.org/doi/10.1146/annurev-med-060712-
Publisher Site
http://dx.doi.org/10.1146/annurev-med-060712-200152DOI Listing
September 2014

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.

Cancer Discov 2014 Feb 23;4(2):216-31. Epub 2014 Jan 23.

1Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, NIH; 2Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland; 3Broad Institute of MIT and Harvard, Cambridge; 4Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Department of Pathology, Harvard Medical School, Boston, Massachusetts; 6University of Nebraska Medical Center, Omaha, Nebraska; 7Department of Pediatrics, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas; and 8Department of Pediatrics, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; 9The Tumour Bank, The Children's Cancer Research Unit, The Children's Hospital at Westmead, Westmead, New South Wales, Australia; 10Department of Oncology, Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462130PMC
February 2014

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation.

Clin Cancer Res 2011 Mar 6;17(6):1616-22. Epub 2010 Dec 6.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060283PMC
March 2011

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.

Nat Rev Cancer 2010 Nov 22;10(11):760-74. Epub 2010 Oct 22.

Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, 777 Preston Research Building, Nashville, Tennessee 37232-6307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2947DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072803PMC
November 2010

Highly active antitumor therapy (HAATT) for epidermal growth factor receptor-mutant lung cancer.

Clin Cancer Res 2010 Nov 9;16(22):5371-3. Epub 2010 Nov 9.

Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-10-2405DOI Listing
November 2010

Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.

Mol Cell Biol 2008 May 10;28(10):3162-76. Epub 2008 Mar 10.

Departments of Biochemistry, Anatomy and Cell Biology, McGill University, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.01734-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423163PMC
May 2008

Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas.

PLoS Med 2007 Oct;4(10):e294

Pao Laboratory, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pmed.0040294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001209PMC
October 2007